EMBO Molecular Medicine (Oct 2012)

A complex of α6 integrin and E‐cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin‐like 6

  • Serena Marchiò,
  • Marco Soster,
  • Sabrina Cardaci,
  • Andrea Muratore,
  • Alice Bartolini,
  • Vanessa Barone,
  • Dario Ribero,
  • Maria Monti,
  • Paola Bovino,
  • Jessica Sun,
  • Raffaella Giavazzi,
  • Sofia Asioli,
  • Paola Cassoni,
  • Lorenzo Capussotti,
  • Piero Pucci,
  • Antonella Bugatti,
  • Marco Rusnati,
  • Renata Pasqualini,
  • Wadih Arap,
  • Federico Bussolino

DOI
https://doi.org/10.1002/emmm.201101164
Journal volume & issue
Vol. 4, no. 11
pp. 1156 – 1175

Abstract

Read online

Abstract Homing of colorectal cancer (CRC) cells to the liver is a non‐random process driven by a crosstalk between tumour cells and components of the host tissue. Here we report the isolation of a liver metastasis‐specific peptide ligand (CGIYRLRSC) that binds a complex of E‐cadherin and α6 integrin on the surface of CRC cells. We identify angiopoietin‐like 6 protein as a peptide‐mimicked natural ligand enriched in hepatic blood vessels of CRC patients. We demonstrate that an interaction between hepatic angiopoietin‐like 6 and tumoural α6 integrin/E‐cadherin drives liver homing and colonization by CRC cells, and that CGIYRLRSC inhibits liver metastasis through interference with this ligand/receptor system. Our results indicate a mechanism for metastasis whereby a soluble factor accumulated in normal vessels functions as a specific ligand for circulating cancer cells. Consistently, we show that high amounts of coexpressed α6 integrin and E‐cadherin in primary tumours represent a poor prognostic factor for patients with advanced CRC.

Keywords